Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Breast Cancer Proteomics and Molecular Heterogeneity

NCT01840293 is registered in ClinicalTrials.gov with Cancer Trials Ireland as lead sponsor.

NCT NCT01840293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01840293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Breast Cancer Proteomics and Molecular Heterogeneity
Lead sponsor
Cancer Trials Ireland
Phase
Observational
Overall status
Recruiting
Start date
February 28, 2013
Completion date
January 31, 2038
Enrollment
1,780 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

primary breast cancer, recurrent/metastatic breast cancer